Raoul Bergner

2.1k total citations
80 papers, 1.1k citations indexed

About

Raoul Bergner is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Raoul Bergner has authored 80 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Rheumatology, 26 papers in Pulmonary and Respiratory Medicine and 18 papers in Oncology. Recurrent topics in Raoul Bergner's work include Vasculitis and related conditions (17 papers), Bone health and treatments (14 papers) and Sarcoidosis and Beryllium Toxicity Research (12 papers). Raoul Bergner is often cited by papers focused on Vasculitis and related conditions (17 papers), Bone health and treatments (14 papers) and Sarcoidosis and Beryllium Toxicity Research (12 papers). Raoul Bergner collaborates with scholars based in Germany, United States and Switzerland. Raoul Bergner's co-authors include M. Uppenkamp, Martin Hoffmann, Ingo Diel, Christian Löffler, Knut A. Grötz, Dirk Henrich, M Wunderlich, Armin Grau, Rüdiger Waldherr and Uwe Haberkorn and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and Annals of the Rheumatic Diseases.

In The Last Decade

Raoul Bergner

72 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raoul Bergner Germany 19 352 347 275 208 202 80 1.1k
Noriko Hayami Japan 22 337 1.0× 153 0.4× 252 0.9× 660 3.2× 85 0.4× 134 1.5k
Rikako Hiramatsu Japan 20 262 0.7× 132 0.4× 177 0.6× 559 2.7× 60 0.3× 104 1.2k
Chan Hong Jeon South Korea 19 203 0.6× 90 0.3× 361 1.3× 64 0.3× 73 0.4× 59 1.0k
Sung Soo Ahn South Korea 19 473 1.3× 104 0.3× 431 1.6× 120 0.6× 163 0.8× 156 1.2k
Chan‐Bum Choi South Korea 24 154 0.4× 120 0.3× 1.0k 3.7× 55 0.3× 104 0.5× 79 1.6k
Geneviève Depresseux Belgium 15 124 0.4× 146 0.4× 654 2.4× 320 1.5× 27 0.1× 23 1.1k
Yuan‐Lan Huang China 16 176 0.5× 475 1.4× 134 0.5× 33 0.2× 60 0.3× 26 969
Alessandro Volpe Italy 21 235 0.7× 86 0.2× 311 1.1× 43 0.2× 56 0.3× 58 1.2k
A Akesson Sweden 22 404 1.1× 78 0.2× 274 1.0× 76 0.4× 99 0.5× 43 1.7k
David A. Laskow United States 21 249 0.7× 402 1.2× 44 0.2× 341 1.6× 40 0.2× 50 2.1k

Countries citing papers authored by Raoul Bergner

Since Specialization
Citations

This map shows the geographic impact of Raoul Bergner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raoul Bergner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raoul Bergner more than expected).

Fields of papers citing papers by Raoul Bergner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raoul Bergner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raoul Bergner. The network helps show where Raoul Bergner may publish in the future.

Co-authorship network of co-authors of Raoul Bergner

This figure shows the co-authorship network connecting the top 25 collaborators of Raoul Bergner. A scholar is included among the top collaborators of Raoul Bergner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raoul Bergner. Raoul Bergner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Triantafyllias, Konstantinos, Muthuraman Muthuraman, George Βertsias, et al.. (2025). Oscillometric, greyscale- and novel color-Doppler-ultrasound indices of macrovascular damage in Sjögren’s: the SICARD cohort study. Arthritis Research & Therapy. 27(1). 164–164.
3.
Porubský, Štefan, et al.. (2024). Clinical and histological comparison of IgA nephritis and renal IgA vasculitis. Nephrology Dialysis Transplantation. 40(1). 182–192. 6 indexed citations
5.
Krämer, Stefan, Thomas Rauen, Martin Busch, et al.. (2023). POS1162 EVALUATION OF THE 2022 ACR/EULAR CLASSIFICATION CRITERIA FOR GPA AND MPA IN A EUROPEAN ANCA-ASSOCIATED VASCULITIS (AAV) COHORT. Annals of the Rheumatic Diseases. 82. 913–913. 1 indexed citations
6.
Krämer, Stefan, Thomas Rauen, Martin Busch, et al.. (2023). POS1173 LONG-TERM ANALYSIS OF RELAPSE RATES IN A EUROPEAN ANCA-ASSOCIATED VASCULITIS (AAV) COHORT FOR GPA AND MPA. Annals of the Rheumatic Diseases. 82. 919–919.
7.
Bergner, Raoul, Peter J. Schulz, & W. Florian. (2023). AB0704 EVALUATION OF THE OF THE 2022 ACR/EULAR CLASSIFICATION CRITERIA FOR GCA IN A GERMAN PATIENT COHORT. Annals of the Rheumatic Diseases. 82. 1555–1556. 1 indexed citations
9.
Bergner, Raoul, et al.. (2023). Renal disease in sarcoidosis patients in a German multicentric retrospective cohort study. Respiratory Medicine. 209. 107121–107121. 7 indexed citations
10.
Bergner, Raoul, et al.. (2022). Single Center Experience Using Monoclonal COVID-19 Antibodies in the Management of Immunocompromised Patients with COVID-19. Microorganisms. 10(12). 2490–2490. 1 indexed citations
11.
Bergner, Raoul, et al.. (2021). Use of Contrast-Enhanced Ultrasound Sonography in Giant Cell Arteritis: A Proof-of-Concept Study. Ultrasound in Medicine & Biology. 48(1). 143–148. 11 indexed citations
12.
Urlaub, Doris, Shuyang Zhao, Norbert Blank, et al.. (2019). Activation of natural killer cells by rituximab in granulomatosis with polyangiitis. Arthritis Research & Therapy. 21(1). 277–277. 9 indexed citations
13.
Löffler, Christian, Johannes Hoffend, Urs Benck, Bernhard K. Krämer, & Raoul Bergner. (2017). The value of ultrasound in diagnosing extracranial large-vessel vasculitis compared to FDG-PET/CT: A retrospective study. Clinical Rheumatology. 36(9). 2079–2086. 32 indexed citations
14.
Bergner, Raoul, et al.. (2015). Nephrotoxicity of ibandronate and zoledronate in Wistar rats with normal renal function and after unilateral nephrectomy. Pharmacological Research. 99. 16–22. 12 indexed citations
15.
Schmitt, Stefan, Thomas Hielscher, Claudia D. Baldus, et al.. (2013). Bisphosphonate treatment and renal function in 201 myeloma patients undergoing stem cell transplantation. International Journal of Hematology. 97(6). 765–772. 2 indexed citations
16.
Bergner, Raoul, et al.. (2012). Determination of renal tissue ibandronate levels in rats with normal and mildly impaired renal function. Journal of Pharmacological and Toxicological Methods. 68(2). 225–230. 5 indexed citations
17.
Bergner, Raoul, et al.. (2012). Leflunomide in dialysis patients with rheumatoid arthritis—a pharmacokinetic study. Clinical Rheumatology. 32(2). 267–270. 21 indexed citations
18.
Bergner, Raoul, et al.. (2008). Treatment of reduced bone density with ibandronate in dialysis patients. Journal of Nephrology. 21(4). 510–516. 33 indexed citations
19.
Bergner, Raoul, Dirk Henrich, Martin Hoffmann, et al.. (2007). Renal Safety and Pharmacokinetics of Ibandronate in Multiple Myeloma Patients With or Without Impaired Renal Function. The Journal of Clinical Pharmacology. 47(8). 942–950. 22 indexed citations
20.
Lenz, Tomas, Stefan Gauer, Herbert A. Weich, et al.. (2005). Vascular endothelial growth factor and its soluble receptor, Flt‐1, are not correlated to erythropoietin in diabetics with normal or reduced renal function. Nephrology. 10(1). 84–89. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026